Indications
Adiva (efavirenz) is used together with other antiretroviral agents to treat HIV-1 infection. This use rests on plasma HIV-RNA levels and CD4 cell counts measured in controlled studies lasting up to 24 weeks. So far there are no results from controlled trials that look at long-term suppression of HIVRNA with Adiva.
⚠️ Always consult a registered physician before taking any medicine.
Pharmacology
Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI) active against HIV-1. It blocks RNA and DNA dependent polymerase activities, including HIV-1 replication.
Pregnancy & Breastfeeding
Efavirenz is classed as Category D in pregnancy. This means there is positive evidence of risk to the human fetus, yet the benefits may still outweigh the risk for some pregnant women. That judgement is usually made when the drug is needed in a life-threatening situation, or for a serious disease where safer medicines cannot be used or do not work.
Lactation
Efavirenz may pass into breast milk and cause serious harm to the baby. It should not be used during lactation.
⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.
Dosage Reference
⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.
Side Effects & Interactions
Side Effects
No side-effect data recorded yet.